Author Question: Why is the kinetic assay considered a more reliable measure of reaction rate than either the ... (Read 65 times)

CBme

  • Hero Member
  • *****
  • Posts: 548
Why is the kinetic assay considered a more reliable measure of reaction rate than either the end-point assay or two-point assay?
 
  A) The kinetic assay compares the results of many different samples.
  B) The kinetic assay measures both the absorbance and kinetic energy of the sample.
  C) The kinetic assay measures the motion of the substrate molecules.
  D) The kinetic assay provides confirmation of the linear relationship between product amount and time.

Question 2

You are provided the following set of data: 20, 21, 28, 42, 43, 43, 50 Which value represents the median of this data set?
 
  A) 20
  B) 36
  C) 42
  D) 43



miss_1456@hotmail.com

  • Sr. Member
  • ****
  • Posts: 289
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library